☰

Eric J. Arts - Publications

Affiliations: 
Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
Biochemistry
Website:
http://case.edu/med/id/faculty/arts_eric.html
Tree Info Similar researchers PubMed Report error

163 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, ... ... Arts E, et al. Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques. Vaccines. 12. PMID 38675751 DOI: 10.3390/vaccines12040369  0.437
2024 Ngo MH, Pankrac J, Ho RCY, Ndashimye E, Pawa R, Ceccacci R, Biru T, Olabode AS, Klein K, Li Y, Kovacs C, Assad R, Jacobson JM, Canaday DH, Tomusange S, ... ... Arts EJ, et al. Effective and targeted latency reversal in CD4 T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection. Emerging Microbes & Infections. 2327371. PMID 38444369 DOI: 10.1080/22221751.2024.2327371  0.54
2024 Tebit DM, Nickel G, Gibson R, Rodriguez M, Hathaway NJ, Bain K, Reyes-Rodriguez AL, Ondoa P, Heeney JL, Li Y, Bongorno J, Canaday D, McDonald D, Bailey JA, Arts EJ. Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans. Ebiomedicine. 100: 104965. PMID 38215691 DOI: 10.1016/j.ebiom.2023.104965  0.362
2023 Jelinski J, Kowatsch MM, Lafrance MA, Berger A, Pedersen J, Azizi H, Li Y, Scholte F, Gomez A, Hollett N, Le T, Wade M, Fausther-Bovendo H, de La Vega MA, Babuadze G, ... ... Arts E, et al. Rhesus Macaques Show Increased Resistance To Repeated SHIV Intrarectal Exposure Following A Heterologous Regimen Of rVSV Vector Vaccine Expressing HIV Antigen. Emerging Microbes & Infections. 2251595. PMID 37649434 DOI: 10.1080/22221751.2023.2251595  0.419
2023 Azizi H, Knapp JP, Li Y, Berger A, Lafrance MA, Pedersen J, de la Vega MA, Racine T, Kang CY, Mann JFS, Dikeakos JD, Kobinger G, Arts EJ. Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV. Vaccines. 11. PMID 37243081 DOI: 10.3390/vaccines11050977  0.388
2023 Bouman JA, Venner CM, Walker C, Arts EJ, Regoes RR. Per-pathogen virulence of HIV-1 subtypes A, C and D. Proceedings. Biological Sciences. 290: 20222572. PMID 37161335 DOI: 10.1098/rspb.2022.2572  0.443
2023 Kohio HP, Ajoge HO, Coleman MD, Ndashimye E, Gibson RM, Arts EJ, Barr SD. Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses. Viruses. 15. PMID 36851678 DOI: 10.3390/v15020465  0.329
2023 Ajoge HO, Renner TM, Bélanger K, Greig M, Dankar S, Kohio HP, Coleman MD, Ndashimye E, Arts EJ, Langlois MA, Barr SD. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature Communications. 14: 16. PMID 36627271 DOI: 10.1038/s41467-022-35379-y  0.477
2022 Bruser G, Luginaah I, Katasi R, Zhang LZ, Namasinga M, Kityo C, Arts E. " Challenges to Antiretroviral Therapy Adherence in Kampala, Uganda. African Geographical Review. 43: 18-31. PMID 38576439 DOI: 10.1080/19376812.2022.2101496  0.414
2022 Ajoge HO, Kohio HP, Paparisto E, Coleman MD, Wong K, Tom SK, Bain KL, Berry CC, Arts EJ, Barr SD. G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential. Viruses. 14. PMID 36423103 DOI: 10.3390/v14112494  0.355
2022 Ndashimye E, Reyes PS, Arts EJ. New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates? Fems Microbiology Reviews. PMID 36130204 DOI: 10.1093/femsre/fuac040  0.532
2022 Ratcliff AN, Venner CM, Olabode AS, Knapp J, Pankrac J, Derecichei I, Gibson RM, Finzi A, Li Y, Mann JFS, Arts EJ. Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope. Journal of Virology. e0185121. PMID 35862673 DOI: 10.1128/jvi.01851-21  0.482
2021 Ndashimye E, Li Y, Reyes PS, Avino M, Olabode AS, Kityo CM, Kyeyune F, Nankya I, Quiñones-Mateu ME, Barr SD, Arts EJ. High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations. The Journal of Antimicrobial Chemotherapy. PMID 34453542 DOI: 10.1093/jac/dkab276  0.476
2021 Ismail SD, Pankrac J, Ndashimye E, Prodger JL, Abrahams MR, Mann JFS, Redd AD, Arts EJ. Addressing an HIV cure in LMIC. Retrovirology. 18: 21. PMID 34344423 DOI: 10.1186/s12977-021-00565-1  0.484
2021 Mumby MJ, Johnson AL, Trothen SM, Edgar CR, Gibson R, Stathopulos PB, Arts EJ, Dikeakos JD. An amino acid polymorphism within the HIV-1 Nef dileucine motif functionally uncouples cell surface CD4 and SERINC5 downregulation. Journal of Virology. JVI0058821. PMID 34037423 DOI: 10.1128/JVI.00588-21  0.47
2021 Ndashimye E, Arts EJ. Dolutegravir response in antiretroviral therapy naïve and experienced patients with M184V/I: Impact in low-and middle-income settings. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 105: 298-303. PMID 33722682 DOI: 10.1016/j.ijid.2021.03.018  0.478
2020 Bruser G, Katasi R, Zhang LZ, Namasinga M, Arts E, Kityo C, Luginaah I. Failure is not an option: Barriers to HIV treatment adherence in Kampala, Uganda. Health & Place. 67: 102481. PMID 33276263 DOI: 10.1016/j.healthplace.2020.102481  0.401
2020 Klein K, Nankya I, Nickel G, Ratcliff AN, Meadows AAJ, Hathaway N, Bailey JA, Stieh DJ, Cheeseman HM, Carias AM, Lobritz MA, Mann JFS, Gao Y, Hope TJ, Shattock RJ, ... Arts EJ, et al. Deep gene sequence cluster analyses of multi-virus infected mucosal tissue reveal enhanced transmission of acute HIV-1. Journal of Virology. PMID 33177204 DOI: 10.1128/JVI.01737-20  0.552
2020 Ndashimye E, Avino M, Olabode AS, Poon AFY, Gibson RM, Li Y, Meadows A, Tan C, Reyes PS, Kityo CM, Kyeyune F, Nankya I, Quiñones-Mateu ME, Arts EJ. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 32853364 DOI: 10.1093/jac/dkaa355  0.432
2020 Mann JFS, Pankrac J, Klein K, McKay PF, King DFL, Gibson R, Wijewardhana CN, Pawa R, Meyerowitz J, Gao Y, Canaday DH, Avino M, Poon AFY, Foster C, Fidler S, ... ... Arts EJ, et al. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection. Ebiomedicine. 102853. PMID 32654992 DOI: 10.1016/J.Ebiom.2020.102853  0.597
2019 Ndashimye E, Arts EJ. The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030. Infectious Diseases of Poverty. 8: 63. PMID 31370888 DOI: 10.1186/s40249-019-0573-1  0.386
2019 Mohammadzadeh N, Love RP, Gibson R, Arts EJ, Poon AFY, Chelico L. Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance. Heliyon. 5: e01498. PMID 31025011 DOI: 10.1016/j.heliyon.2019.e01498  0.531
2019 Ball L, Venner C, Tirona RG, Arts E, Gupta K, Wiener J, Koivu S, Silverman MS. Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated with Sharing Equipment. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31021987 DOI: 10.1097/Qai.0000000000002063  0.482
2019 Poon AFY, Ndashimye E, Avino M, Gibson R, Kityo C, Kyeyune F, Nankya I, Quiñones-Mateu ME, Arts EJ. First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda. Aids Research and Therapy. 16: 3. PMID 30670037 DOI: 10.1186/s12981-019-0218-2  0.462
2018 Shortridge MD, Wille PT, Jones AN, Davidson A, Bogdanovic J, Arts E, Karn J, Robinson JA, Varani G. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb. Nucleic Acids Research. PMID 30481318 DOI: 10.2210/Pdb6D2U/Pdb  0.434
2018 Paparisto E, Woods MW, Coleman MD, Moghadasi SA, Kochar DS, Tom SK, Kohio HP, Gibson RM, Rohringer TJ, Hunt NR, Di Gravio EJ, Zhang JY, Tian M, Gao Y, Arts EJ, et al. Evolution-guided structural and functional analyses of the HERC family reveals an ancient marine origin and determinants of antiviral activity. Journal of Virology. PMID 29669830 DOI: 10.1128/JVI.00528-18  0.318
2018 Pankrac J, Klein K, McKay PF, King DFL, Bain K, Knapp J, Biru T, Wijewardhana CN, Pawa R, Canaday DH, Gao Y, Fidler S, Shattock RJ, Arts EJ, Mann JFS. A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system. Npj Vaccines. 3: 2. PMID 29367885 DOI: 10.1038/s41541-017-0040-6  0.464
2018 Ndashimye E, Avino M, Kyeyune F, Nankya I, Gibson RM, Nabulime E, Poon AFY, Kityo C, Mugyenyi P, Quinones-Mateu ME, Arts E. Absence of HIV-1 drug resistance mutations supports the use of dolutegravir in Uganda. Aids Research and Human Retroviruses. PMID 29353487 DOI: 10.1089/AID.2017.0205  0.373
2018 Klein K, Nickel G, Nankya I, Kyeyune F, Demers K, Ndashimye E, Kwok C, Chen PL, Rwambuya S, Poon A, Munjoma M, Chipato T, Byamugisha J, Mugyenyi P, Salata RA, ... ... Arts EJ, et al. Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection. Plos Pathogens. 14: e1006754. PMID 29346424 DOI: 10.1371/Journal.Ppat.1006754  0.585
2017 Gibson RM, Nickel G, Crawford M, Kyeyune F, Venner C, Nankya I, Nabulime E, Ndashimye E, Poon AFY, Salata RA, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ. Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries. Infectious Diseases of Poverty. 6: 163. PMID 29202874 DOI: 10.1186/S40249-017-0377-0  0.318
2017 Racine T, Kobinger GP, Arts EJ. Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses. Aids Research and Therapy. 14: 55. PMID 28893277 DOI: 10.1186/s12981-017-0179-2  0.367
2017 Bagaya BS, Tian M, Nickel GC, Vega JF, Li Y, He P, Klein K, Mann JFS, Jiang W, Arts EJ, Gao Y. An in vitro Model to Mimic Selection of Replication-competent HIV-1 Intersubtype Recombination in Dual or Superinfected Patients. Journal of Molecular Biology. PMID 28472629 DOI: 10.1016/j.jmb.2017.04.016  0.485
2016 Krebs KC, Tian M, Asmal M, Ling B, Nelson K, Henry K, Gibson R, Li Y, Han W, Shattock RJ, Veazey RS, Letvin N, Arts EJ, Gao Y. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections. Aids Research and Therapy. 13: 41. PMID 27906032 DOI: 10.1186/S12981-016-0125-8  0.593
2016 Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, Wu K, An HY, Mills A, Schneider S, Bredeek UF, Coulston DR, Ding S, Finzi A, Tian M, ... ... Arts EJ, et al. First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses. Retrovirology. 13: 82. PMID 27894306 DOI: 10.1186/S12977-016-0317-2  0.411
2016 Johnson AL, Dirk BS, Coutu M, Haeryfar SM, Arts EJ, Finzi A, Dikeakos JD. A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression. Msphere. 1. PMID 27840851 DOI: 10.1128/mSphere.00288-16  0.44
2016 Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ. Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa. Ebiomedicine. PMID 27751765 DOI: 10.1016/J.Ebiom.2016.10.014  0.56
2016 Asmal M, Lane S, Tian M, Nickel G, Venner C, Dirk B, Dikeakos J, Luedemann C, Mach L, Balachandran H, Buzby A, Rao S, Letvin N, Gao Y, Arts EJ. Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections. Virology. 499: 298-312. PMID 27723488 DOI: 10.1016/J.Virol.2016.09.021  0.619
2016 Kyeyune F, Gibson RM, Nankya I, Venner C, Metha S, Akao J, Ndashimye E, Kityo CM, Salata RA, Mugyenyi P, Arts EJ, Quiñones-Mateu ME. Low Frequency Drug Resistance in HIV-infected Ugandans on Antiretroviral Treatment is Associated with Regimen Failure. Antimicrobial Agents and Chemotherapy. PMID 27001818 DOI: 10.1128/Aac.00038-16  0.624
2016 Tebit DM, Patel H, Ratcliffe A, Alessandri E, Liu J, Carpenter C, Plantier JC, Arts E. HIV-1 group O genotypes and phenotypes: relationship to fitness and susceptibility to antiretroviral drugs. Aids Research and Human Retroviruses. PMID 26861573 DOI: 10.1089/Aid.2015.0318  0.569
2015 Nankya IL, Tebit DM, Abraha A, Kyeyune F, Gibson R, Jegede O, Nickel G, Arts EJ. Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage. Aids Research and Therapy. 12: 34. PMID 26435727 DOI: 10.1186/S12981-015-0066-7  0.564
2015 Bagaya BS, Vega JF, Tian M, Nickel GC, Li Y, Krebs KC, Arts EJ, Gao Y. Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants. Retrovirology. 12: 44. PMID 25997955 DOI: 10.1186/s12977-015-0170-8  0.445
2015 Shytaj IL, Nickel G, Arts E, Farrell N, Biffoni M, Pal R, Chung HK, LaBranche C, Montefiori D, Vargas-Inchaustegui D, Robert-Guroff M, Lewis MG, Sacha JB, Palamara AT, Savarino A. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection. Journal of Virology. 89: 7521-35. PMID 25972547 DOI: 10.1128/Jvi.00396-15  0.547
2015 Rausch JW, Tian M, Li Y, Angelova L, Bagaya BS, Krebs KC, Qian F, Zhu C, Arts EJ, Le Grice SF, Gao Y. SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness. Plos One. 10: e0122953. PMID 25860884 DOI: 10.1371/journal.pone.0122953  0.476
2015 Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O. Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. Aids Research and Human Retroviruses. 31: 421-7. PMID 25317854 DOI: 10.1089/Aid.2014.0081  0.533
2014 Rubio AE, Abraha A, Carpenter CA, Troyer RM, Reyes-Rodríguez AL, Salomon H, Arts EJ, Tebit DM. Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina Plos One. 9. PMID 24727861 DOI: 10.1371/Journal.Pone.0092084  0.592
2014 Liu Y, Rao U, McClure J, Konopa P, Manocheewa S, Kim M, Chen L, Troyer RM, Tebit DM, Holte S, Arts EJ, Mullins JI. Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds. Plos One. 9: e94240. PMID 24713822 DOI: 10.1371/Journal.Pone.0094240  0.578
2014 Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 390-6. PMID 24583613 DOI: 10.1097/Qai.0000000000000006  0.413
2013 Lemonovich TL, Watkins RR, Morrison CS, Kwok C, Chipato T, Musoke R, Arts EJ, Nankya I, Salata RA. Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African Women. Journal of the International Association of Providers of Aids Care. PMID 24106054 DOI: 10.1177/2325957413504827  0.558
2013 Kyeyune F, Nankya I, Metha S, Akao J, Ndashimye E, Tebit DM, Rodriguez B, Kityo C, Salata RA, Mugyenyi P, Arts EJ. Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period Aids. 27: 1899-1909. PMID 23727942 DOI: 10.1097/Qad.0B013E3283610Ec7  0.534
2013 Lobritz MA, Ratcliff AN, Marozsan AJ, Dudley DM, Tilton JC, Arts EJ. Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc. Antimicrobial Agents and Chemotherapy. 57: 2640-50. PMID 23529732 DOI: 10.1128/Aac.02511-12  0.563
2013 Weber J, Vazquez AC, Winner D, Gibson RM, Rhea AM, Rose JD, Wylie D, Henry K, Wright A, King K, Archer J, Poveda E, Soriano V, Robertson DL, Olivo PD, ... Arts EJ, et al. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism. Journal of Clinical Microbiology. 51: 1517-27. PMID 23486708 DOI: 10.1128/Jcm.00092-13  0.618
2013 Chamanian M, Purzycka KJ, Wille PT, Ha JS, McDonald D, Gao Y, Le Grice SF, Arts EJ. A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation. Cell Host & Microbe. 13: 181-92. PMID 23414758 DOI: 10.1016/J.Chom.2013.01.007  0.443
2013 King DF, Siddiqui AA, Buffa V, Fischetti L, Gao Y, Stieh D, McKay PF, Rogers P, Ochsenbauer C, Kappes JC, Arts EJ, Shattock RJ. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus. Journal of Virology. 87: 890-9. PMID 23135721 DOI: 10.1128/Jvi.02216-12  0.467
2013 Ratcliff AN, Shi W, Arts EJ. HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120. Journal of Virology. 87: 923-34. PMID 23135713 DOI: 10.1128/Jvi.01863-12  0.526
2013 Tebit DM, Arts EJ. From Simian to Human Immunodeficiency Viruses (SIV to HIV): Emergence from Nonhuman Primates and Transmission to Humans The Role of Animals in Emerging Viral Diseases. 201-234. DOI: 10.1016/B978-0-12-405191-1.00009-0  0.495
2012 Archer J, Weber J, Henry K, Winner D, Gibson R, Lee L, Paxinos E, Arts EJ, Robertson DL, Mimms L, Quiñones-Mateu ME. Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism. Plos One. 7: e49602. PMID 23166726 DOI: 10.1371/Journal.Pone.0049602  0.594
2012 Arts EJ. Commentary on the role of treatment-related HIV compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block HIV-1 replication. Bmc Medicine. 10: 114. PMID 23031614 DOI: 10.1186/1741-7015-10-114  0.567
2012 Immonen T, Gibson R, Leitner T, Miller MA, Arts EJ, Somersalo E, Calvetti D. A hybrid stochastic-deterministic computational model accurately describes spatial dynamics and virus diffusion in HIV-1 growth competition assay. Journal of Theoretical Biology. 312: 120-32. PMID 22814476 DOI: 10.1016/J.Jtbi.2012.07.005  0.452
2012 Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harbor Perspectives in Medicine. 2: a007161. PMID 22474613 DOI: 10.1101/Cshperspect.A007161  0.536
2012 Santos AF, Tebit DM, Lalonde MS, Abecasis AB, Ratcliff A, Camacho RJ, Diaz RS, Herchenröder O, Soares MA, Arts EJ. Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility. Antimicrobial Agents and Chemotherapy. 56: 2719-25. PMID 22330918 DOI: 10.1128/Aac.06079-11  0.803
2012 Gibson RM, Arts EJ. Past, present, and future of entry inhibitors as HIV microbicides. Current Hiv Research. 10: 19-26. PMID 22264042 DOI: 10.2174/157016212799304616  0.612
2011 Weber J, Vazquez AC, Winner D, Rose JD, Wylie D, Rhea AM, Henry K, Pappas J, Wright A, Mohamed N, Gibson R, Rodriguez B, Soriano V, King K, Arts EJ, et al. Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy. Antimicrobial Agents and Chemotherapy. 55: 3729-42. PMID 21628544 DOI: 10.1128/Aac.00396-11  0.598
2011 Lalonde MS, Lobritz MA, Ratcliff A, Chamanian M, Athanassiou Z, Tyagi M, Wong J, Robinson JA, Karn J, Varani G, Arts EJ. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. Plos Pathogens. 7: e1002038. PMID 21625572 DOI: 10.1371/Journal.Ppat.1002038  0.823
2011 Lobritz MA, Lassen KG, Arts EJ. HIV-1 replicative fitness in elite controllers. Current Opinion in Hiv and Aids. 6: 214-20. PMID 21430530 DOI: 10.1097/Coh.0B013E3283454Cf5  0.546
2011 Morrison CS, Chen PL, Nankya I, Rinaldi A, Van Der Pol B, Ma YR, Chipato T, Mugerwa R, Dunbar M, Arts E, Salata RA. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe Journal of Acquired Immune Deficiency Syndromes. 57: 157-164. PMID 21358412 DOI: 10.1097/Qai.0B013E318214Ba4A  0.548
2011 Gao Y, Abreha M, Nelson KN, Baird H, Dudley DM, Abraha A, Arts EJ. Enrichment of intersubtype HIV-1 recombinants in a dual infection system using HIV-1 strain-specific siRNAs. Retrovirology. 8: 5. PMID 21232148 DOI: 10.1186/1742-4690-8-5  0.619
2011 Tebit DM, Arts EJ. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. The Lancet. Infectious Diseases. 11: 45-56. PMID 21126914 DOI: 10.1016/S1473-3099(10)70186-9  0.583
2011 Krogstad A, Gao Y, Krebs K, Arts E, Hunter M, Labranche C, Montefiori D, Traina-Dorge V, Marx P. A new chimeric SIVmac251/SIVmac239 virus for vaccine studies requiring moderate sensitivity to neutralization and resistance to TRIM5a F1000research. 2. DOI: 10.7490/F1000Research.1089579.1  0.308
2010 Lobritz MA, Ratcliff AN, Arts EJ. HIV-1 Entry, Inhibitors, and Resistance. Viruses. 2: 1069-105. PMID 21994672 DOI: 10.3390/V2051069  0.561
2010 Lalonde MS, Arts EJ. DNA suspension arrays: silencing discrete artifacts for high-sensitivity applications. Plos One. 5: e15476. PMID 21079742 DOI: 10.1371/Journal.Pone.0015476  0.776
2010 Tebit DM, Lobritz M, Lalonde M, Immonen T, Singh K, Sarafianos S, Herchenröder O, Kräusslich HG, Arts EJ. Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. Journal of Virology. 84: 9817-30. PMID 20631150 DOI: 10.1128/Jvi.00991-10  0.774
2010 Morrison CS, Demers K, Kwok C, Bulime S, Rinaldi A, Munjoma M, Dunbar M, Chipato T, Byamugisha J, Van Der Pol B, Arts E, Salata RA. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection Aids. 24: 573-582. PMID 20154581 DOI: 10.1097/Qad.0B013E32833433Df  0.577
2009 Soares EA, Santos AF, Gonzalez LM, Lalonde MS, Tebit DM, Tanuri A, Arts EJ, Soares MA. Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage. The Journal of Antimicrobial Chemotherapy. 64: 938-44. PMID 19710076 DOI: 10.1093/Jac/Dkp315  0.825
2009 Johnston SH, Lobritz MA, Nguyen S, Lassen K, Delair S, Posta F, Bryson YJ, Arts EJ, Chou T, Lee B. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. Journal of Virology. 83: 11016-26. PMID 19692480 DOI: 10.1128/Jvi.01242-09  0.447
2009 Sendagire H, Easterbrook PJ, Nanka I, Arts E, Thomas D, Reynolds SJ. The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART Aids Reviews. 11: 59-70. PMID 19529746  0.508
2009 Dudley DM, Gao Y, Nelson KN, Henry KR, Nankya I, Gibson RM, Arts EJ. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates. Biotechniques. 46: 458-67. PMID 19480640 DOI: 10.2144/000113119  0.631
2009 Christie NM, Willer DO, Lobritz MA, Chan JK, Arts EJ, Ostrowski MA, Cochrane A, Luscher MA, MacDonald KS. Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1 Virology. 388: 137-146. PMID 19368950 DOI: 10.1016/J.Virol.2009.03.003  0.502
2009 Lassen KG, Lobritz MA, Bailey JR, Johnston S, Nguyen S, Lee B, Chou T, Siliciano RF, Markowitz M, Arts EJ. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. Plos Pathogens. 5: e1000377. PMID 19360131 DOI: 10.1371/Journal.Ppat.1000377  0.547
2009 Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, Tebit DM, Zhao H, Avila S, Lobritz MA, McElrath MJ, Le Gall S, Mullins JI, Arts EJ. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. Plos Pathogens. 5: e1000365. PMID 19343217 DOI: 10.1371/Journal.Ppat.1000365  0.528
2009 Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, Shattock RJ, Arts EJ. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. Journal of Virology. 83: 5592-605. PMID 19297481 DOI: 10.1128/Jvi.02051-08  0.566
2009 Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. Aids Care. 21: 271-9. PMID 19280404 DOI: 10.1080/09540120802241863  0.376
2009 Dudley DM, Wentzel JL, Lalonde MS, Veazey RS, Arts EJ. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques. Journal of Virology. 83: 5067-76. PMID 19279098 DOI: 10.1128/Jvi.00055-09  0.815
2009 Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. Journal of the International Association of Physicians in Aids Care (Chicago, Ill. : 2002). 8: 139-47. PMID 19258526 DOI: 10.1177/1545109709332470  0.47
2009 Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, ... ... Arts EJ, et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Journal of Virology. 83: 2743-55. PMID 19116253 DOI: 10.1128/Jvi.02265-08  0.526
2009 Gao Y, Nankya I, Abraha A, Troyer RM, Nelson KN, Rubio A, Arts EJ. Calculating HIV-1 infectious titre using a virtual TCID(50) method. Methods in Molecular Biology (Clifton, N.J.). 485: 27-35. PMID 19020816 DOI: 10.1007/978-1-59745-170-3_3  0.601
2009 Siddiqui AA, King DF, Buffa V, Fischetti L, Ochsenbauer-Jambor C, Gao Y, Krebs KC, Kappes JC, Arts EJ, Shattock RJ. P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P385  0.462
2009 Rolland MM, Swain VJ, Lanxon-Cookson E, Rao U, Henry KR, Arts EJ, Nickle DC, Mullins JI. P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P296  0.419
2009 Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, ... ... Arts EJ, et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition (Journal of Virology (2009) 83, 6, (2743-2755)) Journal of Virology. 83: 5961. DOI: 10.1128/Jvi.00579-09  0.36
2008 Archer J, Pinney JW, Fan J, Simon-Loriere E, Arts EJ, Negroni M, Robertson DL. Identifying the important HIV-1 recombination breakpoints. Plos Computational Biology. 4: e1000178. PMID 18787691 DOI: 10.1371/Journal.Pcbi.1000178  0.568
2008 Troyer RM, Lalonde MS, Fraundorf E, Demers KR, Kyeyune F, Mugyenyi P, Syed A, Whalen CC, Bajunirwe F, Arts EJ. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda. Aids Research and Human Retroviruses. 24: 235-50. PMID 18284323 DOI: 10.1089/Aid.2007.0138  0.788
2008 Gao Y, Lobritz MA, Roth J, Abreha M, Nelson KN, Nankya I, Moore-Dudley DM, Abraha A, Gerson SL, Arts EJ. Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replication. Journal of Virology. 82: 2938-51. PMID 18199654 DOI: 10.1128/Jvi.02126-07  0.564
2008 Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, Salata R, Arts EJ. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. Journal of Clinical Microbiology. 46: 177-84. PMID 17855574 DOI: 10.1128/Jcm.00428-07  0.573
2007 Weber J, Henry KR, Arts EJ, Quiñones-Mateu ME. Viral fitness: relation to drug resistance mutations and mechanisms involved: nucleoside reverse transcriptase inhibitor mutations. Current Opinion in Hiv and Aids. 2: 81-7. PMID 19372871 DOI: 10.1097/Coh.0B013E328051B4E8  0.594
2007 Liu Y, McNevin J, Zhao H, Tebit DM, Troyer RM, McSweyn M, Ghosh AK, Shriner D, Arts EJ, McElrath MJ, Mullins JI. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. Journal of Virology. 81: 12179-88. PMID 17728222 DOI: 10.1128/Jvi.01277-07  0.509
2007 Tebit DM, Nankya I, Arts EJ, Gao Y. HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle? Aids Reviews. 9: 75-87. PMID 17694675  0.51
2007 Lalonde MS, Troyer RM, Syed AR, Bulime S, Demers K, Bajunirwe F, Arts EJ. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies. Journal of Clinical Microbiology. 45: 2604-15. PMID 17567789 DOI: 10.1128/Jcm.00431-07  0.833
2007 Anastassopoulou CG, Marozsan AJ, Matet A, Snyder AD, Arts EJ, Kuhmann SE, Moore JP. Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss. Plos Pathogens. 3: e79. PMID 17542646 DOI: 10.1371/Journal.Ppat.0030079  0.556
2007 Lobritz MA, Marozsan AJ, Troyer RM, Arts EJ. Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity. Journal of Virology. 81: 8258-69. PMID 17522224 DOI: 10.1128/Jvi.02739-06  0.459
2007 Henry KR, Weber J, Quiñones-Mateu ME, Arts EJ. The impact of viral and host elements on HIV fitness and disease progression. Current Hiv/Aids Reports. 4: 36-41. PMID 17338859 DOI: 10.1007/S11904-007-0006-9  0.611
2007 Ariën KK, Vanham G, Arts EJ. Is HIV-1 evolving to a less virulent form in humans? Nature Reviews. Microbiology. 5: 141-51. PMID 17203103 DOI: 10.1038/Nrmicro1594  0.606
2006 Baird HA, Gao Y, Galetto R, Lalonde M, Anthony RM, Giacomoni V, Abreha M, Destefano JJ, Negroni M, Arts EJ. Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination. Retrovirology. 3: 91. PMID 17164002 DOI: 10.1186/1742-4690-3-91  0.816
2006 Baird HA, Galetto R, Gao Y, Simon-Loriere E, Abreha M, Archer J, Fan J, Robertson DL, Arts EJ, Negroni M. Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Research. 34: 5203-16. PMID 17003055 DOI: 10.1093/Nar/Gkl669  0.526
2006 Quiñones-Mateu ME, Arts EJ. Virus fitness: Concept, quantification, and application to HIV population dynamics Current Topics in Microbiology and Immunology. 299: 83-140. PMID 16568897 DOI: 10.1007/3-540-26397-7_4  0.565
2005 Toossi Z, Mayanja-Kizza H, Baseke J, Peters P, Wu M, Abraha A, Aung H, Okwera A, Hirsch C, Arts E. Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis. Clinical and Experimental Immunology. 142: 327-32. PMID 16232220 DOI: 10.1111/J.1365-2249.2005.02913.X  0.589
2005 Ariën KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, Vanham G. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. Aids (London, England). 19: 1555-64. PMID 16184024 DOI: 10.1097/01.Aids.0000185989.16477.91  0.609
2005 Moore DM, Arts EJ, Gao Y, Marozsan AJ. A yeast recombination-based cloning system to produce chimeric HIV-1 viruses and express HIV-1 genes. Methods in Molecular Biology (Clifton, N.J.). 304: 369-85. PMID 16061990 DOI: 10.1385/1-59259-907-9:369  0.561
2005 Abraha A, Troyer RM, Quiñones-Mateu ME, Arts EJ. Methods to determine HIV-1 ex vivo fitness. Methods in Molecular Biology (Clifton, N.J.). 304: 355-68. PMID 16061989 DOI: 10.1385/1-59259-907-9:355  0.645
2005 Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, Krizan RW, Toossi Z, Colebunders RL, Jensen MA, Mullins JI, Vanham G, Arts EJ. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. Journal of Virology. 79: 9006-18. PMID 15994794 DOI: 10.1128/Jvi.79.14.9006-9018.2005  0.624
2005 Ariën KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. Journal of Virology. 79: 8979-90. PMID 15994792 DOI: 10.1128/Jvi.79.14.8979-8990.2005  0.618
2005 Marozsan AJ, Moore DM, Lobritz MA, Fraundorf E, Abraha A, Reeves JD, Arts EJ. Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry. Journal of Virology. 79: 7121-34. PMID 15890952 DOI: 10.1128/Jvi.79.11.7121-7134.2005  0.562
2005 Baird HA, Marozsan AJ, Lederman MM, Landay A, Mildvan D, Kuritzkes DR, Kessler HA, Arts EJ. Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen. Aids Research and Therapy. 2: 2. PMID 15826302 DOI: 10.1186/1742-6405-2-2  0.496
2005 Marozsan AJ, Matet A, Kuhmann SE, Rivera E, Morgan T, Arts EJ, Moore JP. Retrovirology. 2: S9. DOI: 10.1186/1742-4690-2-S1-S9  0.562
2004 Bajunirwe F, Massaquoi I, Asiimwe S, Kamya MR, Arts EJ, Whalen CC. Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda. African Health Sciences. 4: 146-54. PMID 15687066  0.358
2004 Marozsan AJ, Fraundorf E, Abraha A, Baird H, Moore D, Troyer R, Nankja I, Arts EJ. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. Journal of Virology. 78: 11130-41. PMID 15452233 DOI: 10.1128/Jvi.78.20.11130-11141.2004  0.628
2004 Kawamura T, Bruse SE, Abraha A, Sugaya M, Hartley O, Offord RE, Arts EJ, Zimmerman PA, Blauvelt A, Bruce SE. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. Journal of Virology. 78: 7602-9. PMID 15220435 DOI: 10.1128/Jvi.78.14.7602-7609.2004  0.582
2004 Richard N, Juntilla M, Abraha A, Demers K, Paxinos E, Galovich J, Petropoulos C, Whalen CC, Kyeyune F, Atwine D, Kityo C, Mugyenyi P, Arts EJ. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1. Aids Research and Human Retroviruses. 20: 355-64. PMID 15157354 DOI: 10.1089/088922204323048104  0.574
2004 Gao Y, Paxinos E, Galovich J, Troyer R, Baird H, Abreha M, Kityo C, Mugyenyi P, Petropoulos C, Arts EJ. Characterization of a subtype D human immunodeficiency virus type 1 isolate that was obtained from an untreated individual and that is highly resistant to nonnucleoside reverse transcriptase inhibitors. Journal of Virology. 78: 5390-401. PMID 15113918 DOI: 10.1128/Jvi.78.10.5390-5401.2004  0.528
2004 Kawamura T, Bruse SE, Abraha A, Sugaya M, Hartley O, Offord RE, Arts EJ, Zimmerman PA, Blauvelt A. Erratum: PSC-RANTES blocks R5 human immunodeficiency virus infection of langerhans cells isolated from individuals with a variety of CCR5 diplotypes (Journal of Virology (2004) 78, 14 (7602-7609)) Journal of Virology. 78. DOI: 10.1128/Jvi.78.19.10837.2004  0.389
2003 Marozsan AJ, Arts EJ. Development of a yeast-based recombination cloning/system for the analysis of gene products from diverse human immunodeficiency virus type 1 isolates. Journal of Virological Methods. 111: 111-20. PMID 12880926 DOI: 10.1016/S0166-0934(03)00166-6  0.598
2003 Arts EJ, Quiñones-Mateu ME. Sorting out the complexities of HIV-1 fitness. Aids (London, England). 17: 780-1. PMID 12646811 DOI: 10.1097/00002030-200303280-00026  0.551
2003 Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, Quiñones-Mateu ME, Penn-Nicholson A, Murray M, Richard N, Lobritz M, Zimmerman PA, Kawamura T, Blauvelt A, Arts EJ. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. Journal of Virology. 77: 1021-38. PMID 12502818 DOI: 10.1128/Jvi.77.2.1021-1038.2003  0.555
2002 Quiñones-Mateu ME, Arts EJ. Fitness of drug resistant HIV-1: methodology and clinical implications. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 5: 224-33. PMID 12531179 DOI: 10.1016/S1368-7646(02)00123-1  0.631
2002 Collins KR, Quiñones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. Aids Reviews. 4: 165-76. PMID 12416451  0.445
2002 Quiñones-Mateu ME, Gao Y, Ball SC, Marozsan AJ, Abraha A, Arts EJ. In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms. Journal of Virology. 76: 9600-13. PMID 12208939 DOI: 10.1128/Jvi.76.19.9600-9613.2002  0.578
2002 Otieno MW, Banura C, Katongole-Mbidde E, Johnson JL, Ghannoum M, Dowlati A, Renne R, Arts E, Whalen C, Lederman MM, Remick SC. Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa. Journal of the National Cancer Institute. 94: 718-32. PMID 12011222 DOI: 10.1093/Jnci/94.10.718  0.551
2002 Collins KR, Quiñones-Mateu ME, Wu M, Luzze H, Johnson JL, Hirsch C, Toossi Z, Arts EJ. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. Journal of Virology. 76: 1697-706. PMID 11799165 DOI: 10.1128/Jvi.76.4.1697-1706.2002  0.613
2001 Marozsan AJ, Torre VS, Johnson M, Ball SC, Cross JV, Templeton DJ, Quiñones-Mateu ME, Offord RE, Arts EJ. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES. Journal of Virology. 75: 8624-38. PMID 11507208 DOI: 10.1128/Jvi.75.18.8624-8638.2001  0.581
2001 Menéndez-Arias L, Abraha A, Quiñones-Mateu ME, Mas A, Camarasa MJ, Arts EJ. Functional Characterization of Chimeric Reverse Transcriptases with Polypeptide Subunits of Highly Divergent HIV-1 Group M and O Strains Journal of Biological Chemistry. 276: 27470-27479. PMID 11353775 DOI: 10.1074/jbc.M104342200  0.502
2001 Lederman M, Mosier D, Arts E, Letvin N, Flexner C, Blauvelt A, Cairns S, Bridges S, Sarver N, Offord R. Rationale for testing chemokine inhibitors (Virustats) for prevention of HIV-1 transmission. Aids. 15: S57-S58. DOI: 10.1097/00002030-200102001-00081  0.543
2000 Collins KR, Mayanja-Kizza H, Sullivan BA, Quiñones-Mateu ME, Toossi Z, Arts EJ. Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis Journal of Acquired Immune Deficiency Syndromes. 24: 408-417. PMID 11035611 DOI: 10.1097/00126334-200008150-00002  0.614
2000 Quiñones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, Vanham G, van Der Groen G, Colebunders RL, Arts EJ. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. Journal of Virology. 74: 9222-33. PMID 10982369 DOI: 10.1128/Jvi.74.19.9222-9233.2000  0.623
2000 Torre VS, Marozsan AJ, Albright JL, Collins KR, Hartley O, Offord RE, Quiñones-Mateu ME, Arts EJ. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. Journal of Virology. 74: 4868-76. PMID 10775626 DOI: 10.1128/Jvi.74.10.4868-4876.2000  0.592
2000 García Lerma JG, Soriano V, Mas A, Quiñones-Mateu ME, Arts EJ, Heneine W. Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity Journal of Clinical Microbiology. 38: 402-405. PMID 10618125  0.413
2000 Quiñones-Mateu ME, Ball SC, Arts EJ. Role of human immunodeficiency virus type 1 group O in the AIDS pandemic Aids Reviews. 2: 190-202.  0.417
1999 Quiñones-Mateu ME, Albright JL, Torre V, Reinis M, Vandasová J, Brucková M, Arts EJ. Molecular epidemiology of HIV type 1 isolates from the Czech Republic: identification of an env E subtype case. Aids Research and Human Retroviruses. 15: 85-9. PMID 10024058 DOI: 10.1089/088922299311763  0.631
1998 Arts EJ, Quiñones-Mateu ME, Albright JL. Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 1: 21-8. PMID 17092793 DOI: 10.1016/S1368-7646(98)80211-2  0.529
1998 Quiñones-Mateu ME, Albright JL, Mas A, Soriano V, Arts EJ. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1 Journal of Virology. 72: 9002-9015. PMID 9765445 DOI: 10.1128/Jvi.72.11.9002-9015.1998  0.519
1998 Arts EJ, Miller JT, Ehresmann B, Le Grice SFJ. Mutating a region of HIV-1 reverse transcriptase implicated in tRNA(Lys- 3) binding and the consequences for (-)-strand DNA synthesis Journal of Biological Chemistry. 273: 14523-14532. PMID 9603966 DOI: 10.1074/jbc.273.23.14523  0.411
1998 Arts EJ, Quiñones-Mateu ME, Albright JL, Marois JP, Hough C, Gu Z, Wainberg MA. 3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants. Journal of Virology. 72: 4858-65. PMID 9573252 DOI: 10.1128/Jvi.72.6.4858-4865.1998  0.588
1998 Arts EJ, Le Grice SF. Interaction of retroviral reverse transcriptase with template-primer duplexes during replication Progress in Nucleic Acid Research and Molecular Biology. 58: 339-393. PMID 9308371 DOI: 10.1016/S0079-6603(08)60041-0  0.408
1998 Arts EJ, Quiñones-Mateu ME, Albright JL, Marois J, Hough C, Gu Z, Wainberg MA. 3′-Azido-3′-Deoxythymidine (AZT) Mediates Cross-Resistance to Nucleoside Analogs in the Case of AZT-Resistant Human Immunodeficiency Virus Type 1 Variants Journal of Virology. 72: 4858-4865. DOI: 10.1128/jvi.72.6.4858-4865.1998  0.531
1998 Arts EJ, Quiñones-Mateu ME, Albright JL. Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity Drug Resistance Updates. 1: 21-28. DOI: 10.1016/S1368-7646(98)80211-2  0.436
1996 Li Z, Shalom A, Huang Y, Mak J, Arts E, Wainberg MA, Kleiman L. Multiple forms of tRNA(Lys3) in HIV-1. Biochemical and Biophysical Research Communications. 227: 530-40. PMID 8878548 DOI: 10.1006/Bbrc.1996.1541  0.688
1996 Arts EJ, Wainberg MA. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription Antimicrobial Agents and Chemotherapy. 40: 527-540. PMID 8851566 DOI: 10.1128/Aac.40.3.527  0.702
1996 Arts EJ, Wainberg MA. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription Advances in Virus Research. 46: 97-163. PMID 8824699 DOI: 10.1016/S0065-3527(08)60071-8  0.66
1996 Arts EJ, Stetor SR, Li X, Rausch JW, Howard KJ, Ehresmann B, North TW, Wöhrl BM, Goody RS, Wainberg MA, Le Grice SFJ. Initiation of (-) strand DNA synthesis from tRNALys3 on lentiviral RNAs: Implications of specific HIV-1 RNA-tRNALys3 interactions inhibiting primer utilization by retroviral reverse transcriptases Proceedings of the National Academy of Sciences of the United States of America. 93: 10063-10068. PMID 8816751 DOI: 10.1073/Pnas.93.19.10063  0.687
1996 Li X, Quan Y, Arts EJ, Li Z, Preston BD, De Rocquigny H, Roques BP, Darlix JL, Kleiman L, Parniak MA, Wainberg MA. Human immunodeficiency virus type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA3/(Lys) in vitro: Studies of viral RNA molecules mutated in regions that flank the primer binding site Journal of Virology. 70: 4996-5004. PMID 8764006 DOI: 10.1128/Jvi.70.8.4996-5004.1996  0.559
1996 Rausch JW, Arts EJ, Wöhrl BM, Le Grice SFJ. Involvement of C-terminal structural elements of equine infectious anemia virus reverse transcriptase in DNA polymerase and ribonuclease H activities Journal of Molecular Biology. 257: 500-511. PMID 8648620 DOI: 10.1006/Jmbi.1996.0181  0.314
1996 Arts EJ, Ghosh M, Jacques PS, Ehresmann B, Le Grice SFJ. Restoration of tRNA3Lys-primed (-)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs Implications for retroviral replication Journal of Biological Chemistry. 271: 9054-9061. PMID 8621554 DOI: 10.1074/Jbc.271.15.9054  0.514
1996 Arts EJ, Marois JP, Zhengxian GU, Le Grice SFJ, Wainberg MA. Effects of 3′-deoxynucleoside 5′-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA Journal of Virology. 70: 712-720. PMID 8551607 DOI: 10.1128/Jvi.70.2.712-720.1996  0.694
1996 Li X, Quan Y, Arts EJ, Li Z, Preston BD, de Rocquigny H, Roques BP, Darlix JL, Kleiman L, Parniak MA, Wainberg MA. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. Journal of Virology. 70: 4996-5004. DOI: 10.1128/jvi.70.8.4996-5004.1996  0.473
1995 Gu Z, Quan Y, Li Z, Arts EJ, Wainberg MA. Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays Journal of Biological Chemistry. 270: 31046-31051. PMID 8537362 DOI: 10.1074/Jbc.270.52.31046  0.681
1995 Wainberg MA, Gu Z, Salomon H, Arts EJ, Kleiman L, Parniak MA, Morin N. Molecular basis and clinical significance of HIV-1 resistance to nucleoside compounds Comptes Rendus De L"Academie Des Sciences. Serie Iii, Sciences De La Vie. 318: 315-328. PMID 7540494  0.497
1995 Gu Z, Arts EJ, Parniak MA, Wainberg MA. Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2′,3′-dideoxycytidine 5′-triphosphate and other drugs Proceedings of the National Academy of Sciences of the United States of America. 92: 2760-2764. PMID 7535930 DOI: 10.1073/Pnas.92.7.2760  0.672
1995 Arts EJ, Li Z, Wainberg MA. Analysis of primer extension and the first template switch during human immunodeficiency virus reverse transcription Journal of Biomedical Science. 2: 314-321. DOI: 10.1007/Bf02255218  0.641
1994 Arts EJ, Wainberg MA. Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription Antimicrobial Agents and Chemotherapy. 38: 1008-1016. PMID 7915097 DOI: 10.1128/Aac.38.5.1008  0.671
1994 Gu Z, Fletcher RS, Arts EJ, Wainberg MA, Parniak MA. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-3′-thiacytidine, and 2′,3′-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro Journal of Biological Chemistry. 269: 28118-28122. PMID 7525567  0.45
1994 Li X, Mak J, Arts EJ, Gu Z, Kleiman L, Wainberg MA, Parniak MA. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication Journal of Virology. 68: 6198-6206. PMID 7521916 DOI: 10.1128/Jvi.68.10.6198-6206.1994  0.563
1994 Arts EJ, Mak J, Kleiman L, Wainberg MA. DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity Journal of General Virology. 75: 1605-1613. PMID 7517431 DOI: 10.1099/0022-1317-75-7-1605  0.628
1994 Arts EJ, Li X, Gu Z, Kleiman L, Parniak MA, Wainberg MA. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction Journal of Biological Chemistry. 269: 14672-14680. PMID 7514178  0.337
1994 Arts EJ, Mak J, Kleiman L, Wainberg MA. Mature reverse transcriptase (p66/p51) is responsible for low levels of viral DNA found in human immunodeficiency virus type 1 (HIV-1) Leukemia. 8. PMID 7512179  0.404
1993 Geleziunas R, Arts EJ, Boulerice F, Goldman H, Wainberg MA. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages Antimicrobial Agents and Chemotherapy. 37: 1305-1312. PMID 8392310 DOI: 10.1128/Aac.37.6.1305  0.656
1993 St Luce S, Arts E, Geleziunas R, Bour S, Wainberg MA. Infection of human monocyte-derived macrophages by human immunodeficiency virus mediated by cell-to-cell transmission. Journal of Medical Virology. 41: 71-8. PMID 7693862 DOI: 10.1002/Jmv.1890410115  0.683
Show low-probability matches.